BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 17414950)

  • 1. Emerging cytokine targets in rheumatoid arthritis.
    Asquith DL; McInnes IB
    Curr Opin Rheumatol; 2007 May; 19(3):246-51. PubMed ID: 17414950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update on cytokines in rheumatoid arthritis.
    Brennan F; Beech J
    Curr Opin Rheumatol; 2007 May; 19(3):296-301. PubMed ID: 17414959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic targets for rheumatoid arthritis: Progress and promises.
    Alghasham A; Rasheed Z
    Autoimmunity; 2014 Mar; 47(2):77-94. PubMed ID: 24437572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokine networks--towards new therapies for rheumatoid arthritis.
    McInnes IB; Liew FY
    Nat Clin Pract Rheumatol; 2005 Nov; 1(1):31-9. PubMed ID: 16932625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Future trends in the treatment of rheumatoid arthritis: cytokine targets.
    Breedveld FC
    Rheumatology (Oxford); 1999 Nov; 38 Suppl 2():11-3. PubMed ID: 10646483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New cytokine targets in inflammatory rheumatic diseases.
    Connell L; McInnes IB
    Best Pract Res Clin Rheumatol; 2006 Oct; 20(5):865-78. PubMed ID: 16980211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging targets of biologic therapies for rheumatoid arthritis.
    Tarner IH; Müller-Ladner U; Gay S
    Nat Clin Pract Rheumatol; 2007 Jun; 3(6):336-45. PubMed ID: 17538565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenesis of rheumatoid arthritis: targeting cytokines.
    Zwerina J; Redlich K; Schett G; Smolen JS
    Ann N Y Acad Sci; 2005 Jun; 1051():716-29. PubMed ID: 16127012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Joint inflammation and cytokine inhibition in rheumatoid arthritis.
    Christodoulou C; Choy EH
    Clin Exp Med; 2006 Mar; 6(1):13-9. PubMed ID: 16550339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokine inhibitors in rheumatoid arthritis and other autoimmune diseases.
    Williams RO; Paleolog E; Feldmann M
    Curr Opin Pharmacol; 2007 Aug; 7(4):412-7. PubMed ID: 17627887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular therapeutic targets in rheumatoid arthritis.
    Sacre SM; Andreakos E; Taylor P; Feldmann M; Foxwell BM
    Expert Rev Mol Med; 2005 Aug; 7(16):1-20. PubMed ID: 16117838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of T cells in rheumatoid arthritis: new subsets and new targets.
    Toh ML; Miossec P
    Curr Opin Rheumatol; 2007 May; 19(3):284-8. PubMed ID: 17414957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cytokines in rheumatoid arthritis. I. Proinflammatory cytokines].
    Klimiuk PA; Sierakowski S
    Pol Merkur Lekarski; 2001 Dec; 11(66):510-3. PubMed ID: 11899850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokines in the pathogenesis of rheumatoid arthritis.
    McInnes IB; Schett G
    Nat Rev Immunol; 2007 Jun; 7(6):429-42. PubMed ID: 17525752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutralizing IL-21 and IL-15 inhibits pro-inflammatory cytokine production in rheumatoid arthritis.
    Andersson AK; Feldmann M; Brennan FM
    Scand J Immunol; 2008 Jul; 68(1):103-11. PubMed ID: 18482208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. At the horizon of innovative therapy in rheumatology: new biologic agents.
    Finckh A; Gabay C
    Curr Opin Rheumatol; 2008 May; 20(3):269-75. PubMed ID: 18388517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular mechanisms of inflammatory bone damage: emerging targets for therapy.
    Herman S; Krönke G; Schett G
    Trends Mol Med; 2008 Jun; 14(6):245-53. PubMed ID: 18468489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokine targeting in psoriasis and psoriatic arthritis: beyond TNFalpha.
    MclInnes IB
    Ernst Schering Res Found Workshop; 2006; (56):29-44. PubMed ID: 16329645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Signalling, inflammation and arthritis: crossed signals: the role of interleukin (IL)-12, -17, -23 and -27 in autoimmunity.
    Paunovic V; Carroll HP; Vandenbroeck K; Gadina M
    Rheumatology (Oxford); 2008 Jun; 47(6):771-6. PubMed ID: 18238793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What is after cytokine-blocking therapy, a novel therapeutic target--synovial Epstein-Barr virus for rheumatoid arthritis.
    Sawada S; Takei M; Inomata H; Nozaki T; Shiraiwa H
    Autoimmun Rev; 2007 Jan; 6(3):126-30. PubMed ID: 17289546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.